unani medicine for anal fissure

To evaluate the efficacy of Unani formulation (zaroor) in comparison to zaroor-e-Aelwa in shiqaq-e-miqâ??ad (anal fissure) patients.

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2023/05/052857

Enrollment

Registered

2023-05-18

Start date

Unknown

Completion date

Unknown

Last updated

2023-05-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K602- Anal fissure, unspecified

Interventions

Intervention1: UNANI FORMULATION (ZAROOR): CONTENTS OF UNANI FORMULATION: 1. ANZAROOT: 2. GULNAAR: 3. KUNDUR:. 4. ZARAWAND: In the form of zaroor (Fine powder) locally applied over the anal fissure

Eligibility

Inclusion criteria

Inclusion criteria: Anal Fissure (Anterior and/or Posterior)

Exclusion criteria

Exclusion criteria: 1. Fissure associated with 3rd, 4th degree, or thrombosed pile mass. 2. Pregnant women. 3. Malignancy. 4. Severe systemic diseases.

Design outcomes

Primary

Measure	Time frame
1. Pain during and after defecation (VAS) 0-10 grade. 2. Per Rectal Bleeding (present or absent). Objective Assessment: 3. Healing of fissure Grade (Yes/No). 4. Tenderness by digital examination (Yes/No). 5. Anal sphincter spasm (Yes/No).Timepoint: 35 DAYS	—

Secondary

Measure	Time frame
1. Tenderness by digital examination (Yes/No). 2. Anal sphincter spasm (Yes/No). 3. Per Rectal Bleeding (present or absent).Timepoint: 35 DAYS	—

Countries

India

Contacts

Public ContactDr Mohammad Shakeel Ansari

National Institute of Unani Medicine

msnium@gmail.com7411219599

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026